• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Kodak buys software rights

Article

Front Porch Digital has agreed to sell Eastman Kodak exclusive rights to its DIVArchive software for use in medical imaging and IT. Kodak paid $850,000 for the right to apply the software to medical applications. The software serves as a building block

Front Porch Digital has agreed to sell Eastman Kodak exclusive rights to its DIVArchive software for use in medical imaging and IT. Kodak paid $850,000 for the right to apply the software to medical applications. The software serves as a building block in networks, allowing one IT system to manage the content of others to which it is linked. Kodak's Health Imaging Group will offer the software as a stand-alone product or in combination with its PACS offerings. In Europe, Kodak has been offering DIVA Medical Software to its PACS customers through a relationship Kodak and Front Porch forged more than a year ago. Under the new agreement, Front Porch retains all other rights to DIVArchive and will continue to offer the product to the broadcast industry and other market segments.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.